Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE): doubly-modified water-soluble derivatives of chloroorienticin B

Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE): doubly-modified water-soluble derivatives of chloroorienticin B New glycopeptide antibiotics: II. The isolation and structures of chloroorienticins. New glycopeptide antibiotics. I. The structures of orienticins. Synthesis and evaluation of ether and halogenated derivatives of mannopeptimycin glycopeptide antibiotics Solid-phase synthesis and antibacterial evaluations of N-demethylvancomycin derivatives Surprising Alteration of Antibacterial Activity of 5′′-Modified Neomycin against Resistant Bacteria Novel ether derivatives of mannopeptimycin glycopeptide antibiotic Combinatorial modification of natural products: synthesis and in vitro analysis of derivatives of thiazole peptide antibiotic GE2270 A: A-ring modifications Synthesis and in vitro activity of new oxazolidinone antibacterial agents having substituted isoxazoles Probing the Role of the Vancomycin E-Ring Aryl Chloride: Selective Divergent Synthesis and Evaluation of Alternatively Substituted E-Ring Analogues